Document is current
Any future updates will be listed below
-
Authors
Singer, Susanne https://orcid.org/0000-0001-5784-7964
Sykiotis, Gerasimos https://orcid.org/0000-0002-9565-4941
Al-Ibraheem, Akram https://orcid.org/0000-0002-0978-4716
Pinto, Monica https://orcid.org/0000-0002-0823-4907
Iakovou, Ioannis
Østhus, Arild Andre https://orcid.org/0000-0002-0583-4106
Hammerlid, Eva https://orcid.org/0000-0002-1813-108X
Locati, Laura Deborah https://orcid.org/0000-0003-3315-2580
Gamper, Eva Maria https://orcid.org/0000-0002-1700-4054
Arraras, Juan Ignacio https://orcid.org/0000-0002-4415-2570
Jordan, Susan https://orcid.org/0000-0002-4566-1414
Buettner, Matthias https://orcid.org/0000-0002-7000-8257
Engesser, Deborah https://orcid.org/0000-0001-8377-1553
Taylor, Katherine https://orcid.org/0000-0003-0768-5789
Canotilho, Rita https://orcid.org/0000-0003-3914-0679
Ioannidis, Georgios https://orcid.org/0000-0003-2535-7279
Husson, Olga https://orcid.org/0000-0002-1387-8686
Gama, Ricardo Ribeiro https://orcid.org/0000-0003-4406-8958
Fanetti, Giuseppe https://orcid.org/0000-0002-9677-3176
Moss, Laura
Inhestern, Johanna https://orcid.org/0000-0003-4613-2810
Andry, Guy https://orcid.org/0000-0001-7410-6519
Rimmele, Harald
Kiyota, Naomi https://orcid.org/0000-0001-8021-6116
-
Funding
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (002/2017)
Japan Agency for Medical Research and Development (21ck0106498h0003)
- License Information
-
More Information
Article History
Received: 10 August 2023
Accepted: 23 November 2023
First Online: 16 December 2023
Compliance with ethical standards
:
: S.S. has received honoraria from Lilly for reviewing papers for their Quality of Life Award and from Eisei for advice in writing a paper, outside of the submitted work. N.K. reports honoraria from ONO PHARMACEUTICAL, Bristol Meyers Squibb, Merck Biopharma, Astra-Zeneca, Merck Sharp & Dohme, Eisai, Bayer and Chugai Pharmaceutical, all outside the submitted work. M.P. reports speaker fees from Meeting&Words and from Hinovia S.r.l., outside the submitted work. G.S. has received research support in the form of donations from Merck Sharp & Dohme, IBSA and Alpha-Sigma, which partially defrayed costs associated with recruiting patients in this study. M.B. has received speaker fees from Lilly and Takeda outside of the submitted work. All authors have a special interest in quality of life in thyroid cancer patients and survivors. The authors declare that they have no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.
: Written informed consent was obtained from all individual participants included in the study.
: All procedures performed were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki Declaration and its later amendments of comparable ethical standards. All sites obtained ethical approval in accordance with regional and national requirements. Approval number from the principal investigator’s institution: 837.406.17 (11240).
